miniddy的部落格

LONDON, Jan.迷你倉 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Analyzing the Global Market for Active Pharmaceutical IngredientsThe global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the year 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market.The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.Aruvian Research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expiries of blockbuster drugs and the impact of the economic recession on the market.An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.An analysis of the major industry players such as Teva, Albemarle, Actavis, Boehringer, Cipla and others are included in this in-depth report on the global market for Active Pharmaceutical Ingredients.A. Executive SummaryB. Introduction to Active Pharmaceutical IngredientsC. Global Market for Active Pharmaceutical Ingredients (APIs)C.1 Industry OverviewC.2 Industry RevenuesC.3 Industry SegmentationC.3.1 Biotech API MarketC.3.2 Synthetic API MarketC.4 Brief Profile: High Potency Active Pharmaceutical Ingredients (HPAPIs)D. Impacts on the Global API MarketD.1 Impact of the Economic RecessionD.2 Impact of Patent Expiries & Growing Uptake of BiologicsD.3 Increased Price Competition & Price Cuts by GovernmentsD.4 Growing Number of Mergers & Acquisitions & Increased Global CoverageD.5 Regulatory FrameworkE. Market for Active Pharmaceutical Ingredients (APIs) in Asia PacificE.1 Industry OverviewE.2 Industry RevenuesE.3 Industry SegmentationE.3.1 Biotech API MarketE.3.2 Synthetic API MarketE.4 Therapeutic Applications of API in Asia PacificE.5 Impacts on the IndustryF. Market for Active Pharmaceutical Ingredients (APIs) in ChinaF.1 Industry OverviewF.2 Industry RevenuesF.3 Industry SegmentationF.3.1 Biotech API MarketF.3.2 Synthetic API MarketG. Market for Active Pharmaceutical Ingredients (APIs) in IndiaG.1 Industry OverviewG.2 Industry RevenuesG.3 Industry SegmentationG.3.1 Biotech API MarketG.3.2 Synthetic API MarketH. Market for Active Pharmaceutical Ingredients (APIs) in JapanH.1 Industry OverviewH.2 Industry RevenuesH.3 Industry SegmentationH.3.1 Biotech API MarketH.3.2 Synthetic API MarketI. Market for Active Pharmaceutical Ingredients (APIs) in South KoreaI.1 Industry OverviewI.2 Industry RevenuesI.3 Industry SegmentationI.3.1 Biotech API MarketI.3.2 Synthetic API MarketJ. Market for Active Pharmaceutical Ingredients (APIs) in EuropeJ.1 Industry OverviewJ.2 Industry RevenuesJ.3 Industry SegmentationJ.3.1 Biotech API MarketJ.3.2 Synthetic API MarketJ.4 Therapeutic Applications of API in EuropeJ.5 Impacts on the IndustryK. Market for Active Pharmaceutical Ingredients (APIs) in FranceK.1 Industry OverviewK.2 Industry RevenuesK.3 Industry SegmentationK.3.1 Biotech API MarketK.3.2 Synthetic API MarketL. Market for Active Pharmaceutical Ingredients (APIs) in GermanyL.1 Industry OverviewL.2 Industry RevenuesL.3 Industry SegmentationL.3.1 Biotech API MarketL.3.2 Synthetic API MarketM. Market for Active Pharmaceutical Ingredients (APIs) in ItalyM.1 Industry OverviewM.2 Industry RevenuesM.3 Industry SegmentationM.3.1 Biotech API MarketM.3.2 Synthetic API MarketN. Market for Active Pharmaceutical Ingredients (APIs) in SpainN.1 Industry OverviewN.2 Industry RevenuesN.3 Industry SegmentationN.3.1 Biotech API MarketN.3.2 Synthetic API MarketO. Market for Active Pharmaceutical Ingredients (APIs) in United KingdomO.1 Industry OverviewO.2 Industry RevenuesO.3 Industry SegmentationO.3.1 Biotech API MarketO.3.2 Synthetic API MarketP. Market for Active Pharmaceutical Ingredients (APIs) in North AmericaP.1 Industry OverviewP.2 Industry RevenuesP.3 Industry SegmentationP.3.1 Biotech API MarketP.3.2 Synthetic API MarketP.4 Therapeutic Applications of API in North AmericaP.5 Impacts on the IndustryQ. Market for Active Pharmaceutical Ingredients (APIs) in CanadaQ.1 Industry OverviewQ.2 Industry RevenuesQ.3 Industry SegmentationQ.3.1 Biotech API MarketQ.3.2 Synthetic API MarketR. Market for Active Pharmaceutical Ingredients (APIs) in the USR.1 Industry OverviewR.2 Industry RevenuesR.3 Industry SegmentationR.3.1 Biotech API MarketR.3.2 Synthetic API MarketS. Major Industry PlayersS.1 Albemarle CorporationS.2 Actavis PlcS.3 Ampac Fine Chemicals LLCS.4 Aptuit, IncS.5 Aurobindo PharmaS.6 BASF SES.7 Biocon LtdS.8 Boehringer Ingelheim GmbHS.9 Bristol-Myers Squibb CompanyS.10 Cambrex CorporationS.11 Cipla LtdS.12 Covidien PlcS.13 Daiichi Fine Chemical Co., Ltd.S.14 Dishman Pharmaceuticals & Chemicals Ltd.S.15 Dr. Reddy's Laboratories LimitedS.16 Fabbrica Italiana SinteticiS.17 Hospira IncS.18 Koninklijke DSM N.V.S.19 Lonza Group AGS.20 Lupin LimitedS.21 Matrix Laboratories Limited/Mylan IncS.22 Novartis AGS.23 Novasep HoldingS.24 Pfizer IncS.25 Ranbaxy LaboratoriesS.26 Sandoz International GmbHS.27 Sigma-Aldrich CorporationS.28 Sun Pharmaceutical Industries LimitedS.29 Teva Pharmaceutical Industries LimitedS.30 WuXi AppTec, IncT. Glossary of TermsList of FiguresFigure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018Figure 2: Global API Industry Segmentation by Revenues (%), 2012Figure 3: Revenues of the Global Biotech API Market (in USD Million), 2006-2018Figure 4: Share of the Global Biotech API Market by Regions (%), 2012Figure 5: Share of Revenues of the Global Biotech API Market by Regions (%), 2006-2018Figure 6: Share of the Global Biotech API Market by Application Sector (%), 2012Figure 7: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2006-2018Figure 8: Revenues of the Global Synthetic API Market (in USD Million), 2006-2018Figure 9: Share of the Global Synthetic API Market by Regions (%), 2012Figure 10: Share of Revenues of the Global Synthetic API Market by Regions (%), 2006-2018Figure 11: Share of the Global Synthetic API Market by Application Sector (%), 2012Figure 12: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2006-2018Figure 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2006-2018Figure 14: Asia Pacific API Industry Segmentation by Revenues (%), 2012Figure 15: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2006-2018Figure 16: Share of the Biotech API Market in Asia Pacific by Countries (%), 2012Figure 17: Performance & Growth of the Biotech API Market in Asia Pacific (%), 2006-2018Figure 18: Share of Revenues of the Biotech API Market in Asia Pacific by Countries (%), 2006-2018Figure 19: Share of the Biotech API Market in Asia Pacific by Application Sector (%), 2012Figure 20: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018Figure 21: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2006-2018Figure 22: Share of the Synthetic API Market in Asia Pacific by Countries (%), 2012Figure 23: Performance & Growth of the Synthetic API Market in Asia Pacific (%), 2006-2018Figure 24: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (%), 2006-2018Figure 25: Share of the Synthetic API Market in Asia Pacific by Application Sector (%), 2012Figure 26: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018Figure 27: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2012 & 2018Figure 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2006-2018Figure 29: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2006-2018Figure 30: Share of China Biotech API Market by Application Sector (%), 2012Figure 31: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2006-2018Figure 32: Share of the Synthetic API Market in China by Application Sector (%), 2006-2018Figure 33: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2006-2018Figure 34: India API Industry Segmentation by Revenues (%), 2006-2018Figure 35: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2006-2018Figure 36: Share of the Biotech API Market in India by Application Sector (%), 2006-2018Figure 37: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2006-2018Figure 38: Share of the Synthetic API Market in India by Application Sector (%), 2006-2018Figure 39: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2006-2018Figure 40: Product Type & Revenue Share of the API Market in Japan (%), 2006-2018Figure 41: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2006-2018Figure 42: Share of the Biotech API Market in Japan by Application Sector (%), 2006-2018Figure 43: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2006-2018Figure 44: Share of the Synthetic API Market in Japan by Application Sector (%), 2006-2018Figure 45: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2006-2018Figure 46: South Korea API Industry Segmentation by Revenues (%), 2012Figure 47: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2006-2018Figure 48: Share of the South Korea Biotech API Market by Application Sector (%), 2006-2018Figure 49: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2006-2018Figure 50: Share of the Synthetic API Market in South Korea by Application Sector (%), 2006-2018Figure 51: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018Figure 52: European API Industry Segmentation by Revenues (%), 2012Figure 53: Revenues of the European Biotech API Market (in USD Million), 2006-2018Figure 54: Share of the European Biotech API Market by Countries (%), 2012Figure 55: Performance & Growth of the Biotech API Market in Europe (%), 2006-2018Figure 56: Share of Revenues of the European Biotech API Market by Countries (%), 2006-2018Figure 57: Share of the European Biotech API Market by Application Sector (%), 2012Figure 58: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2006-2018Figure 59: Revenues of the European Synthetic API Market (in USD Million), 2006-2018Figure 60: Share of the European Synthetic API Market by Countries (%), 2012Figure 61: Performance & Growth of the Synthetic API Market in Europe (%), 2006-2018Figure 62: Share of Revenuself storages of the Europe Synthetic API Market by Countries (%), 2006-2018Figure 63: Share of the European Synthetic API Market by Application Sector (%), 2012Figure 64: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2006-2018Figure 65: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2012 & 2018Figure 66: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2006-2018Figure 67: France API Industry Segmentation by Revenues (%), 2006-2018Figure 68: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2006-2018Figure 69: Share of the Biotech API Market in France by Application Sector (%), 2006-2018Figure 70: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2006-2018Figure 71: Share of the Synthetic API Market in France by Application Sector (%), 2006-2018Figure 72: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2006-2018Figure 73: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2006-2018Figure 74: Share of the Biotech API Market in Germany by Application Sector (%), 2006-2018Figure 75: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2006-2018Figure 76: Share of the Synthetic API Market in Germany by Application Sector (%), 2006-2018Figure 77: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2006-2018Figure 78: Italy API Industry Segmentation by Revenues (%), 2006-2018Figure 79: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2006-2018Figure 80: Share of the Biotech API Market in Italy by Application Sector (%), 2006-2018Figure 81: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2006-2018Figure 82: Share of the Synthetic API Market in Italy by Application Sector (%), 2006-2018Figure 83: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2006-2018Figure 84: Spain API Industry Segmentation by Revenues (%), 2006-2018Figure 85: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2006-2018Figure 86: Share of the Biotech API Market in Spain by Application Sector (%), 2006-2018Figure 87: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2006-2018Figure 88: Share of the Synthetic API Market in Spain by Application Sector (%), 2006-2018Figure 89: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2006-2018Figure 90: UK API Industry Segmentation by Revenues (%), 2006-2018Figure 91: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2006-2018Figure 92: Share of the Biotech API Market in UK by Application Sector (%), 2006-2018Figure 93: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2006-2018Figure 94: Share of the Synthetic API Market in UK by Application Sector (%), 2006-2018Figure 95: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2006-2018Figure 96: Industry Segmentation of the Active Pharmaceutical Ingredients (API) Market in North America by Revenues (%), 2006-2018Figure 97: Revenues of the Biotech API Market in North America (in USD Million), 2006-2018Figure 98: Share of the Biotech API Market in North America by Countries (%), 2012Figure 99: Performance & Growth of the Biotech API Market in North America (%), 2006-2018Figure 100: Share of Revenues of the Biotech API Market in North America by Countries (%), 2006-2018Figure 101: Share of the Biotech API Market in North America by Application Sector (%), 2012Figure 102: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2006-2018Figure 103: Revenues of the Synthetic API Market in North America (in USD Million), 2006-2018Figure 104: Share of the Synthetic API Market in North America by Countries (%), 2012Figure 105: Performance & Growth of the Synthetic API Market in North America (%), 2006-2018Figure 106: Share of Revenues by Countries in North America Synthetic API Industry (%), 2006-2018Figure 107: Share of the Synthetic API Market in North America by Application Sector (%), 2012Figure 108: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2006-2018Figure 109: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2012 & 2018Figure 110: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2006-2018Figure 111: Revenue Share of the API Market in Canada by Industry Segments (%), 2006-2018Figure 112: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2006-2018Figure 113: Share of the Canada Biotech API Market by Application Sector (%), 2006-2018Figure 114: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2006-2018Figure 115: Share of the Canada Synthetic API Market by Application Sector (%), 2006-2018Figure 116: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2006-2018Figure 117: Revenue Share of the API Market in the US by Industry Segments (%), 2006-2018Figure 118: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2006-2018Figure 119: Share of the US Biotech API Market by Application Sector (%), 2006-2018Figure 120: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2006-2018Figure 121: Share of the US Synthetic API Market by Application Sector (%), 2006-2018List of TablesTable 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018Table 2: Revenues of the Global Biotech API Market (in USD Million), 2006-2018Table 3: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2006-2018Table 4: Revenues of the Global Synthetic API Market (in USD Million), 2006-2018Table 5: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2006-2018Table 6: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2006-2018Table 7: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2006-2018Table 8: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018Table 9: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2006-2018Table 10: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2006-2018Table 11: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2012 & 2018Table 34: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2006-2018Table 35: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2006-2018Table 36: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2006-2018Table 37: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2006-2018Table 38: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2006-2018Table 39: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2006-2018Table 40: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2006-2018Table 41: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2006-2018Table 42: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2006-2018Table 43: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2006-2018Table 44: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2006-2018Table 45: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2006-2018Table 12: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2006-2018Table 13: Revenues of the European Biotech API Market (in USD Million), 2006-2018Table 14: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2006-2018Table 15: Revenues of the European Synthetic API Market (in USD Million), 2006-2018Table 16: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2006-2018Table 17: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2012 & 2018Table 18: Pricing & Reimbursement Mechanism in Top Markets in Europe, 2012Table 19: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2006-2018Table 20: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2006-2018Table 21: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2006-2018Table 22: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2006-2018Table 23: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2006-2018Table 24: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2006-2018Table 25: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2006-2018Table 26: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2006-2018Table 27: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2006-2018Table 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2006-2018Table 29: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2006-2018Table 30: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2006-2018Table 31: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2006-2018Table 32: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2006-2018Table 33: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2006-2018Table 46: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2006-2018Table 47: Revenues of the Biotech API Market in North America (in USD Million), 2006-2018Table 48: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2006-2018Table 49: Revenues of the Synthetic API Market in North America (in USD Million), 2006-2018Table 50: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2006-2018Table 51: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2012 & 2018Table 52: Drugs with Patent Expiries till 2017Table 53: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2006-2018Table 54: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2006-2018Table 55: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2006-2018Table 56: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2006-2018Table 57: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2006-2018Table 58: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2006-2018Companies MentionedAlbemarle CorporationActavis PlcAmpac Fine Chemicals LLCAptuit, IncAurobindo PharmaBASF SEBiocon LtdBoehringer Ingelheim GmbHBristol-Myers Squibb CompanyCambrex CorporationCipla LtdCovidien PlcDaiichi Fine Chemical Co., Ltd.Dishman Pharmaceuticals & Chemicals Ltd.Dr. Reddy's Laboratories LimitedFabbrica Italiana SinteticiHospira IncKoninklijke DSM N.V.Lonza Group AGLupin LimitedMatrix Laboratories Limited/Mylan IncNovartis AGNovasep HoldingPfizer IncRanbaxy LaboratoriesSandoz International GmbHSigma-Aldrich CorporationSun Pharmaceutical Industries LimitedTeva Pharmaceutical Industries LimitedWuXi AppTec, IncRead the full report:Analyzing the Global Market for Active Pharmaceutical Ingredients .reportbuyer.com/telecoms/data/analyzing_global_market_active_pharmaceutical_ingredients.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=IT_HostingFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: .reportbuyer.comReportBuyerWeb site: .reportbuyer.com/迷利倉